Literature DB >> 19180272

[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: CEIPC 2008 Spanish adaptation].

José M Lobos1, Miguel A Royo-Bordonada, Carlos Brotons, Luís Alvarez-Sala, Pedro Armario, Antonio Maiques, Dídac Mauricio, Susana Sans, Fernando Villar, Angel Lizcano, Antonio Gil-Núñez, Fernando de Alvaro, Pedro Conthe, Emilio Luengo, Alfonso Del Río, Olga Cortés-Rico, Ana de Santiago, Miguel A Vargas, Mercedes Martínez, Vicenta Lizarbe.   

Abstract

We present the Spanish adaptation from the CEIPC of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The aim is to prevent premature mortality and morbidity due to CVD by means of dealing with its related risk factors in clinical practice. The guide focuses on primary prevention and emphasizes the role of the nurses and primary care medical doctors in promoting a healthy life style, based on increasing physical activity, change dietary habits, and non smoking. The therapeutic goal is to achieve a Blood Pressure <140/90 mmHg, but among patients with diabetes, chronic kidney disease, or definite CVD, the objective is <130/80 mmHg. Serum cholesterol should be <200 mg/dl and cLDL <130 mg/dl, although among patients with CVD or diabetes, the objective is <100 mg/dl (80 mg/dl if feasible in very high-risk patients). Patients with type 2 diabetes and those with metabolic syndrome must lose weight and increase their physical activity, and drugs must be administered whenever applicable, with the objective guided by BMI -body mass index- and waist circumference. In diabetic type 2 patients, the objective is glycated haemoglobin <7%. Allowing people to know the guides and developing implementation programs, identifying barriers and seeking solutions for them, are priorities for the CEIPC in order to put the recommendations into practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19180272     DOI: 10.1590/s1135-57272008000600002

Source DB:  PubMed          Journal:  Rev Esp Salud Publica        ISSN: 1135-5727


  11 in total

1.  [Diabetes mellitus and cardiovascular risk. Is integrated therapy of type 2 diabetes and cardiovascular risk factors necessary?].

Authors:  Domingo Orozco Beltrán; Carlos de la Sen Fernández; Vicente Gil Guillén; Concepción Carratalá Munuera; Jorge Navarro Pérez
Journal:  Aten Primaria       Date:  2010-09       Impact factor: 1.137

2.  A moderate intake of phytosterols from habitual diet affects cholesterol metabolism.

Authors:  T Sanclemente; I Marques-Lopes; M Fajó-Pascual; M Cofán; E Jarauta; E Ros; J Puzo; A L García-Otín
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

3.  EDUCORE project: a clinical trial, randomised by clusters, to assess the effect of a visual learning method on blood pressure control in the primary healthcare setting.

Authors:  Isidro Rodríguez-Salceda; Esperanza Escortell-Mayor; Milagros Rico-Blázquez; Rosario Riesgo-Fuertes; Angel Asúnsolo-del Barco; Antonio Valdivia-Pérez; Isabel del Cura-González; Ana B García-Cañón; María F Ortiz-Jiménez; Luisa Cabello-Ballesteros; Sofia Garrido-Elustondo; Laura Chamorro-González; Ricardo Rodríguez-Barrientos
Journal:  BMC Public Health       Date:  2010-07-30       Impact factor: 3.295

4.  Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol.

Authors:  Salvador Pita-Fernández; Sonia Pértega-Díaz; Francisco Valdés-Cañedo; Rocio Seijo-Bestilleiro; Teresa Seoane-Pillado; Constantino Fernández-Rivera; Angel Alonso-Hernández; Dolores Lorenzo-Aguiar; Beatriz López-Calvino; Andres López-Muñiz
Journal:  BMC Cardiovasc Disord       Date:  2011-01-10       Impact factor: 2.298

5.  Effectiveness of Motivational Interviewing in improving lipid level in patients with dyslipidemia assisted by general practitioners: Dislip-EM study protocol.

Authors:  Luis A Pérula; Josep M Bosch; Julia Bóveda; Manuel Campiñez; Nieves Barragán; Juan C Arboniés; Jose A Prados; Enrique Martín; Remedios Martín; Josep Massons; Margarita Criado; Roger Ruiz; José A Fernández; Francisco Buitrago; Inmaculada Olaya; Modesto Pérez; Joaquin Ruiz
Journal:  BMC Fam Pract       Date:  2011-11-05       Impact factor: 2.497

6.  Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial.

Authors:  Ignacio Párraga-Martínez; Joseba Rabanales-Sotos; Fernando Lago-Deibe; Juan M Téllez-Lapeira; Francisco Escobar-Rabadán; Alejandro Villena-Ferrer; Mariano Blasco-Valle; José M Ferreras-Amez; Susana Morena-Rayo; José M del Campo-del Campo; Maria Candelaria Ayuso-Raya; José J Pérez-Pascual
Journal:  BMC Cardiovasc Disord       Date:  2015-01-19       Impact factor: 2.298

7.  Variability in screening prevention activities in primary care in Spain: a multilevel analysis.

Authors:  Magdalena Rosell-Murphy; Teresa Rodriguez-Blanco; Julio Morán; Mariona Pons-Vigués; Josep M Elorza-Ricart; Jordi Rodríguez; Clara Pareja; María Ángeles Nuin; Bonaventura Bolíbar
Journal:  BMC Public Health       Date:  2015-05-07       Impact factor: 3.295

8.  [New European guidelines for cardiovascular prevention and its Spanish adaptation].

Authors:  Carlos Brotons Cuixart; José Maria Lobos Bejarano
Journal:  Aten Primaria       Date:  2017-04       Impact factor: 1.137

9.  [Smoking intervention in patients with cardiovascular diseases].

Authors:  José Ignacio de Granda-Orive; Segismundo Solano-Reina; Carlos Andrés Jiménez-Ruiz
Journal:  Aten Primaria       Date:  2012-03-10       Impact factor: 1.137

10.  Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care.

Authors:  Carlos Brotons; José Maria Lobos; Miguel Ángel Royo-Bordonada; Antonio Maiques; Ana de Santiago; Ángel Castellanos; Santiago Diaz; Juan Carlos Obaya; Juan Pedro-Botet; Irene Moral; Vicenta Lizarbe; Rosa Moreno; Antonio Pérez; Alberto Cordero; Francisco Fornés-Ubeda; Benilde Serrano-Saiz; Miguel Camafort-Babkowski; Roberto Elosua; Susana Sans; Carmen de Pablo; Antonio Gil-Nuñez; Fernando de Álvaro-Moreno; Pedro Armario; Olga Cortés Rico; Fernando Villar; Ángel Lizcano
Journal:  BMC Fam Pract       Date:  2013-03-18       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.